# Feasibility Study of the Intravascular Ventricular Assist System (iVAS)

Study · id `cardio:ct-nct02645539` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02645539](<https://clinicaltrials.gov/study/NCT02645539>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02645539

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT02645539. Allocation not applicable; no masking; primary purpose treatment. Start 2016-04 (actual); primary completion 2020-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT02645539, source copy `cardio:ctgov-nct02645539-2019-11-13`, retrieved 2026-10-26)
- Started: 2016-04 (actual) (ClinicalTrials.gov record NCT02645539, source copy `cardio:ctgov-nct02645539-2019-11-13`, retrieved 2026-10-26)
- Primary completion: 2020-07 (anticipated) (ClinicalTrials.gov record NCT02645539, source copy `cardio:ctgov-nct02645539-2019-11-13`, retrieved 2026-10-26)
- Completion: 2020-12 (anticipated) (ClinicalTrials.gov record NCT02645539, source copy `cardio:ctgov-nct02645539-2019-11-13`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02645539, source copy `cardio:ctgov-nct02645539-2019-11-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02645539-2019-11-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Feasibility Study of the Intravascular Ventricular Assist System (iVAS)
- Condition: Heart Failure NYHA Class III
- Condition: Heart Failure NYHA Class IV
- Intervention (Device): intravascular ventricular assist system (iVAS)
- Lead sponsor: NuPulseCV
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

## Provenance

Content hash: bfea46eb10fcb709e0a7a1c9a62330c2b69efbe9d27ed695799e12540b5c1096
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
